Revise Phase III CT protocol of Olokizumab as a single-arm study: CDSCO Panel Tells Dr Reddys Dr. Divya Colin17 Oct 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Dr...
Olokizumab superior to placebo and noninferior to adalimumab in RA patients Dr. Shravani Dali22 Sept 2022 8:30 PM ISTIn patients with rheumatoid arthritis who were receiving maintenance methotrexate, olokizumab was superior to placebo and noninferior to adalimumab...
Olokizumab Outperforms Placebo in RA patients on maintenance Methotrexate: NEJM Dr. Kamal Kant Kohli29 Aug 2022 8:00 AM ISTVIENNA: Patients with rheumatoid arthritis taking maintenance methotrexate respond better to olokizumab than to a placebo and non-inferior to...
Olokizumab safe and effective for treatment of rheumatoid arthritis: BMJ MD Editorial Team25 Sept 2021 9:00 AM ISTRussia: Treatment with Olokizumab (OKZ) was linked with considerable improvement in signs, symptoms, and physical function of rheumatoid arthritis, as...
Dr Reddys proposal for emergency use approval of Olokizumab for Covid-19 rejected by CDSCO panel MD Bureau2 Feb 2021 7:59 PM ISTNew Delhi: In a setback to Dr Reddy's Laboratories Limited, the Central Drugs Standard Control Organization (CDSCO) committee has rejected its...
